In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
RXO Inc (NYSE: RXO) closed the day trading at $12.49 down -7.82% from the previous closing price of $13.55. In other words, the price has decreased by -$7.82 from its previous closing price. On the day, 3.25 million shares were traded. RXO stock price reached its highest trading level at $13.24 during the session, while it also had its lowest trading level at $12.165.
Ratios:
For a better understanding of RXO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.
On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.
Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2049757184 and an Enterprise Value of 2706757376. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 1.30. Its current Enterprise Value per Revenue stands at 0.456 whereas that against EBITDA is 20.506.
Stock Price History:
The Beta on a monthly basis for RXO is 1.67, which has changed by -0.5753145 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $31.11, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is -25.18%, while the 200-Day Moving Average is calculated to be -26.69%.
Shares Statistics:
Over the past 3-months, RXO traded about 1.98M shares per day on average, while over the past 10 days, RXO traded about 1914660 shares per day. A total of 164.10M shares are outstanding, with a floating share count of 160.70M. Insiders hold about 2.08% of the company’s shares, while institutions hold 105.71% stake in the company. Shares short for RXO as of 1760486400 were 11394086 with a Short Ratio of 5.75, compared to 1757894400 on 9359531. Therefore, it implies a Short% of Shares Outstanding of 11394086 and a Short% of Float of 19.43.
Earnings Estimates
The stock of RXO Inc (RXO) is currently being evaluated by 11.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.03, with high estimates of $0.02 and low estimates of -$0.12.
Analysts are recommending an EPS of between $0.03 and $0.0 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.25, with 16.0 analysts recommending between $0.5 and $0.1.
Revenue Estimates
16 analysts predict $1.5B in revenue for. The current quarter. It ranges from a high estimate of $1.61B to a low estimate of $1.4B. As of. The current estimate, RXO Inc’s year-ago sales were $1.67BFor the next quarter, 16 analysts are estimating revenue of $1.41B. There is a high estimate of $1.5B for the next quarter, whereas the lowest estimate is $1.31B.
A total of 17 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $5.88B, while the lowest revenue estimate was $5.67B, resulting in an average revenue estimate of $5.78B. In the same quarter a year ago, actual revenue was $4.55BBased on 19 analysts’ estimates, the company’s revenue will be $6B in the next fiscal year. The high estimate is $6.43B and the low estimate is $5.73B.
